WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in AURA — Aura Biosciences, Inc.

CIK 1632972 PLYMOUTH, MN

Position in AURA

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$127,374

+$40,940 QoQ

Shares Held

17,940

+38.9% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 17 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. AURA ranks #103 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$127,374	17,940	+38.9%	Shares	Sole	2026-07-15
2026-03-31	$86,434	12,920	+10.2%	Shares	Sole	2026-04-08
2025-12-31	$63,895	11,724	-0.8%	Shares	Sole	2026-01-08
2025-09-30	$73,029	11,817	-0.3%	Shares	Sole	2025-10-29
2025-06-30	$74,199	11,853	-23.2%	Shares	Sole	2025-07-10
2025-03-31	$90,460	15,437	+3.5%	Shares	Sole	2025-04-16
2024-12-31	$122,551	14,909	+0.1%	Shares	Sole	2025-03-17
2024-09-30	$132,678	14,891	+0.2%	Shares	Sole	2024-10-24
2024-06-30	$112,394	14,867	+0.3%	Shares	Sole	2024-07-16
2024-03-31	$116,344	14,821	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.